Incannex Healthcare Inc.
For the period ended Mar 31, 2026. Filed May 15, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 15, 2026
IXHL$2.01-8.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations and Comprehensive Loss
| For the three months ended March 31, | For the nine months ended March 31, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Revenue from customers | - | - | - | 86 |
| Operating expenses: | ||||
| Research and development | (321) | (2,735) | (3,721) | (7,045) |
| General and administrative | (3,727) | (2,268) | (14,115) | (9,302) |
| Total operating expenses | (4,048) | (5,003) | (17,836) | (16,347) |
| Loss from operations | (4,048) | (5,003) | (17,836) | (16,261) |
| Other income, net: | ||||
| R&D tax incentive | 82 | 421 | 953 | 2,188 |
| Foreign exchange gains/(losses) | 25 | 41 | (12) | (290) |
| Interest expense | - | (132) | - | (303) |
| Interest income | 6 | 4 | 16 | 60 |
| Change in fair value of convertible rights | - | - | - | (179) |
| Change in fair value of warrant liabilities | 380 | 1,824 | 380 | 1,721 |
| Warrant issuance costs | (284) | (129) | (284) | (129) |
| Loss on extinguishment | - | (994) | - | (994) |
| ELOC commitment fee | - | - | - | (1,095) |
| Share of earnings (loss) of joint venture | (44) | - | (28) | - |
| Total other income, net | 165 | 1,035 | 1,025 | 979 |
| Loss before income tax expense | (3,883) | (3,968) | (16,811) | (15,282) |
| Income tax expense | - | - | - | - |
| Net loss | (3,883) | (3,968) | (16,811) | (15,282) |
| Other comprehensive income/(loss): | ||||
| Currency translation adjustment, net of tax | (468) | (88) | (532) | (163) |
| Total comprehensive loss | $(4,351) | $(4,056) | $(17,343) | $(15,445) |
| Net loss per share: Basic and diluted | $(0.35) | $(6.19) | $(1.51) | $(25.39) |
| Weighted average number of shares outstanding, basic and diluted | 12,348,460 | 654,418 | 11,451,276 | 607,962 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.